Comments to FDA: Considering Whether an FDA-Regulated Product Involves the Application of Nanotechnology

Docket Number:

FDA-2010-D-0530

CHPA applauds the approach for creating a public forum to collect current research and comments to advance the science of engineered nanomaterials.

Issues:

OTC Medicines